Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Xiao-Wen Zhang
Xin-Lin Zhang
Biao Xu
Li-Na Kang
机构：
[1] Nanjing University School of Medicine,Department of Endocrinology, Affiliated Drum Tower Hospital
[2] Nanjing University School of Medicine,Department of Cardiology, Affiliated Drum Tower Hospital
来源：
Acta Diabetologica | 2018年 / 55卷
关键词：
Insulin degludec; Insulin glargine; Hypoglycemia; Meta-analysis; Randomized controlled trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 441
页数：12
相关论文
共 50 条
  • [1] Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials
    Zhang, Xiao-Wen
    Zhang, Xin-Lin
    Xu, Biao
    Kang, Li-Na
    ACTA DIABETOLOGICA, 2018, 55 (05) : 429 - 441
  • [2] Comparative efficiency and safety of insulin degludec/aspart with insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials
    Long, Tao
    Lin, Jin-ting
    Lin, Min-hua
    Wu, Qian-long
    Lai, Jian-mei
    Li, Sheng-zhen
    Zhou, Zi-chao
    Zeng, Ji-yuan
    Huang, Jia-shuan
    Zeng, Chun-ping
    Lai, Yao-ming
    ENDOCRINE JOURNAL, 2022, 69 (08) : 959 - 969
  • [3] Efficacy and safety of iGlarLixi versus insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials
    Li, Jingxin
    Wang, Xiaomin
    Wu, Jingcheng
    Geng, Dandan
    Li, Fan
    Liu, Yang
    Shen, Yanhong
    ENDOCRINE, 2025,
  • [4] Local tolerability of insulin degludec is comparable to insulin glargine: a meta-analysis of trials in type 1 and type 2 diabetes
    Meneghini, L. F.
    Schumm-Draeger, P. -M.
    Harris, S.
    Gall, M. -A.
    Lassota, N.
    Christiansen, J. S.
    DIABETOLOGIA, 2012, 55 : S380 - S380
  • [5] SAFETY AND EFFICACY OF INSULIN GLARGINE/LIXISENATIDE AND INSULIN DEGLUDEC/INSULIN ASPART IN TYPE 2 DIABETES PATIENTS NOT CONTROLLED ON BASAL INSULIN: A NETWORK META-ANALYSIS
    Jammah, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A185 - A186
  • [6] Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials
    Bazzano, L. A.
    Lee, L. J.
    Shi, L.
    Reynolds, K.
    Jackson, J. A.
    Fonseca, V.
    DIABETIC MEDICINE, 2008, 25 (08) : 924 - 932
  • [7] Efficacy and Safety of Insulin Degludec/Insulin Aspart versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
    Niu, Yan-Li
    Zhang, Ye
    Song, Zhi-Yong
    Zhao, Chuan-Zhi
    Luo, Yun
    Wang, Yan
    Yuan, Jing
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (02) : 313 - 322
  • [8] Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
    Alhmoud, Eman N.
    Saad, Mohamed Omar
    Omar, Nabil Elhadi
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [9] Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
    Vora, Jiten
    Christensen, Torsten
    Rana, Azhar
    Bain, Steve C.
    DIABETES THERAPY, 2014, 5 (02) : 435 - 446
  • [10] Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
    Jiten Vora
    Torsten Christensen
    Azhar Rana
    Steve C. Bain
    Diabetes Therapy, 2014, 5 : 435 - 446
12345